GRIMES & COMPANY, INC. - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 45 filers reported holding REGULUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
GRIMES & COMPANY, INC. ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$26,000
+36.8%
88,203
+44.4%
0.00%0.0%
Q4 2021$19,000
-61.2%
61,076
-14.8%
0.00%
-50.0%
Q3 2021$49,000
-3.9%
71,671
+13.3%
0.00%0.0%
Q2 2021$51,000
-46.3%
63,262
+3.7%
0.00%
-60.0%
Q1 2021$95,000
+28.4%
60,991
+11.9%
0.01%
+25.0%
Q4 2020$74,000
+516.7%
54,511
+127.1%
0.00%
+300.0%
Q3 2020$12,000
-7.7%
23,998
+23.1%
0.00%0.0%
Q2 2020$13,00019,4980.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,851,851$951,0000.11%
BVF INC/IL 3,217,480$1,654,0000.09%
NEA Management Company, LLC 2,052,455$1,055,0000.04%
McGuire Investment Group, LLC 24,000$12,0000.00%
WEDBUSH SECURITIES INC 70,204$36,0000.00%
GRIMES & COMPANY, INC. 23,998$12,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 1,200$1,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 64,347$33,0000.00%
MILLENNIUM MANAGEMENT LLC 49,497$25,0000.00%
View complete list of REGULUS THERAPEUTICS INC shareholders